HQE
benzene-1,4-diol
Created: | 2012-03-14 |
Last modified: | 2024-09-27 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 14 |
Chiral Atom Count | 0 |
Bond Count | 14 |
Aromatic Bond Count | 6 |
Chemical Component Summary | |
---|---|
Name | benzene-1,4-diol |
Systematic Name (OpenEye OEToolkits) | benzene-1,4-diol |
Formula | C6 H6 O2 |
Molecular Weight | 110.111 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | Oc1ccc(O)cc1 |
SMILES | CACTVS | 3.370 | Oc1ccc(O)cc1 |
SMILES | OpenEye OEToolkits | 1.7.6 | c1cc(ccc1O)O |
Canonical SMILES | CACTVS | 3.370 | Oc1ccc(O)cc1 |
Canonical SMILES | OpenEye OEToolkits | 1.7.6 | c1cc(ccc1O)O |
InChI | InChI | 1.03 | InChI=1S/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8H |
InChIKey | InChI | 1.03 | QIGBRXMKCJKVMJ-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB09526 |
---|---|
Name | Hydroquinone |
Groups |
|
Description | Hydroquinone is a topical lightening product found in OTC products, and is used to correct skin discoloration associated with disorders of hyperpigmentation including melasma, post-inflammatory hyperpigmention, sunspots, and freckles. It can be used alone, but is more frequently found in combination with other agents such as alpha-hydroxy acids, corticosteroids, retinoids, or sunscreen. Hydroquinone has come under scrutiny due to several complications associated with its use, including dermal irritation, exogenous onchronosis, and carginogenicity. As a result of these concerns, hydroquinone has been banned in the EU and UK. |
Synonyms |
|
Brand Names |
|
Indication | Hydroquinone is used as an OTC topical lightening agent for disorders of hyperpigmentation including melasma, post-inflammatory hyperpigmention, sunspots and freckles. |
Categories |
|
ATC-Code | D11AX11 |
CAS number | 123-31-9 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Tyrosinase | MLLAVLYCLLWSFQTSAGHFPRACVSSKNLMEKECCPPWSGDRSPCGQLS... | unknown | inhibitor |
Cysteinyl leukotriene receptor 1 | MDETGNLTVSSATCHDTIDDFRNQVYSTLYSMISVVGFFGNGFVLYVLIK... | unknown | activator |
Lysosomal alpha-glucosidase | MGVRHPPCSHRLLAVCALVSLATAALLGHILLHDFLLVPRELSGSSPVLE... | unknown | product of |
Serum albumin | MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL537 |
PubChem | 785 |
ChEMBL | CHEMBL537 |
ChEBI | CHEBI:17594 |
CCDC/CSD | BATRET, CPFEHQ, CIRWEG, AXILUQ, EBILUX, BOKHUG, CEFDOG, COHWIF01, CISCOW, CAKZEV, DOMBEN, BIRQUO, EDAYUG, COZZIB, EDAYEQ, BAVKOA, CABWAD, COHWIF03, ABORAM, COZZOH, BAMZUN01, ACESIL, BAMZUN, AVEKER, EBIMEI, COHWIF02, BUSPAG, BZMETD, EKESIY04, EKESIY05, DIZCEV, DAMPOZ, DAMPOZ01, EKESIY01, EKESIY02, BAMZUN02, EKESIY03, EKESIY06, EKESAQ02, EKESAQ01, ABOQUF, BACRAB, CIPLES, CARWUP, BAMZUN03, COHWIF, CARWUP02, CARWUP01, AVEKIY |
COD | 2100714, 2100715, 2100716, 2100717, 2211791, 2103388, 2204577, 2100228, 2100231 |